Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent brief depression--past and future.

Lukas Pezawas1, Jules Angst, Alex Gamma

  • 1Department of General Psychiatry, University of Vienna, Vienna, Austria. pezawas@nariya.nimh.nih.gov

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

[Digital health applications for depressive disorders in Germany : A narrative review of the evidence and integration into treatment].

Der Nervenarzt·2025
Same author

Facial Affect Recognition and Executive Function Abnormalities in ADHD Subjects: An ERP Study.

Clinical EEG and neuroscience·2024
Same author

Correction: The Minimal Phenomenal Experience questionnaire (MPE-92M): Towards a phenomenological profile of "pure awareness" experiences in meditators.

PloS one·2024
Same author

Hypomania-Checklist-33: risk stratification and factor structure in a mixed psychiatric adolescent sample.

International journal of bipolar disorders·2024
Same author

Outcomes of electroconvulsive therapy in patients with depressive symptoms with versus without comorbid personality disorders/traits: A systematic review and meta-analysis.

Acta psychiatrica Scandinavica·2023
Same journal

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Altered dorsal striatal subregional connectivity associated with distinct executive function deficits in first-episode, drug-naïve major depressive disorder: Evidence from functional connectivity and granger causality analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Chronic pain and stress: unravelling the common neuroinflammatory, immune and endocrine mechanisms for novel therapeutic approaches.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Predicting anhedonia and negative cognitive processing changes after 8-week SSRIs treatment in depression from individual differential structural covariance network.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Mapping intrinsic neural timescale alterations in major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Probiotics in reducing negative symptoms of schizophrenia: A systematic review and meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
See all related articles

Recurrent brief depressive disorder (RBD) involves frequent, short depressive episodes, increasing suicide risk. Current research highlights diagnostic and treatment challenges, necessitating new study designs for effective interventions.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • Recurrent brief depressive disorder (RBD) is a prevalent affective disorder with significant clinical impairment.
  • RBD episodes occur monthly, lasting only a few days, and increase suicide risk.
  • Co-occurrence with major depressive disorder (MDD) further elevates suicide attempt risk.

Purpose of the Study:

  • To review diagnostic criteria and methodological challenges in Recurrent Brief Depressive Disorder (RBD).
  • To discuss the implications of RBD's unique course on clinical practice and drug treatment studies.
  • To highlight the need for improved research methodologies to establish effective treatment algorithms.

Main Methods:

  • Review of existing diagnostic criteria (ICD-10, DSM-IV) for RBD.

Related Experiment Videos

  • Analysis of methodological differences between RBD and MDD in clinical trials.
  • Examination of previous treatment study limitations and outcomes.

    • Main Results:

    • RBD presents distinct diagnostic and drug response evaluation challenges compared to MDD.
    • Clinical management of RBD may resemble approaches used for episodic conditions like migraine or epilepsy.
    • Previous drug treatment studies for RBD, despite some positive findings, were limited by methodological issues, leading to inconclusive results.

    Conclusions:

    • Establishing a definitive treatment algorithm for RBD remains challenging due to methodological limitations in prior studies.
    • Future research requires novel study designs to overcome previous limitations and effectively evaluate RBD treatments.
    • Further investigation is crucial for developing evidence-based interventions for Recurrent Brief Depressive Disorder.